
Boston Scientific Reports $5.44 Billion in Second Quarter Sales
Boston Scientific Corporation posted second-quarter net sales of $5.44 billion, marking a 7.5 percent increase compared to the same period last year. The medical device manufacturer, led by CEO Mike Mahoney, reported GAAP net income of $907 million as it continues to expand its cardiovascular and MedSurg portfolios.
























